Vesalius Therapeutics has entered into an agreement with GSK to advance the development of new therapies for Parkinson’s…
Articles by Margarida Maia, PhD
A type of RNA structure called G-quadruplex, or G4 — a four-stranded RNA structure that forms when calcium enters cells…
Two newly identified brain pathways originating from the striosome — a cluster of nerve cells (neurons) in the striatum, a…
A rapid release of the chemical messenger dopamine in the brain is not needed for initiating movement, while it’s important…
Fatigue is the most common complaint among people with Parkinson’s disease, according to anecdotal data from a free app…
Researchers have identified six probiotics — live bacteria usually used as dietary supplements to help with digestion — with the…
Neural microtissues derived from pluripotent stem cells (iPSCs) can replace dopaminergic neurons, the nerve cells that are lost in…
Both a misfolded form of the alpha-synuclein protein and an inflammatory cue are needed to trigger the Lewy bodies that…
A single dose of CAP-003, a gene therapy being developed by Capsida Biotherapeutic, significantly increased the levels of GCase…
App-based consumer technology like Rune Labs’ StrivePD may help people with Parkinson’s disease feel more confident in managing…